- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT05889182
Een studie om verandering in ziekteactiviteit en bijwerkingen van oraal upadacitinib te beoordelen bij volwassen en adolescente deelnemers met matige tot ernstige hidradenitis suppurativa die anti-TNF-therapie niet hebben doorstaan (Step-Up HS)
Een gerandomiseerde, placebo-gecontroleerde, dubbelblinde fase 3-studie om de werkzaamheid en veiligheid van upadacitinib te evalueren bij volwassen en adolescente proefpersonen met matige tot ernstige hidradenitis suppurativa die geen anti-TNF-therapie hebben ondergaan
Hidradenitis suppurativa (HS) is an inflammatory skin disease that causes painful lesions in the axilla (underarm), inguinal (groin) and anogenital (anal/genital) regions. This study will assess how safe and effective upadacitinib is in treating adult and adolescent participants with moderate to severe HS who have failed to respond to or are intolerant of anti-tumor necrosis factor (TNF) therapy. Adverse events and change in disease activity will be assessed.
Upadacitinib is an approved drug for ulcerative colitis, atopic dermatitis, rheumatoid arthritis, psoriatic arthritis, and axial spondylarthritis and is being developed for the treatment of HS. This study is "double-blinded", meaning that neither the trial participants nor the study doctors will know who will be given upadacitinib and who will be given placebo. This study is comprised of 3 periods. In Period 1, participants are randomized into 2 groups called treatment arms where each group receives a different treatment. There is a 1 in 2 chance that participants will be assigned to placebo. In Period 2, participants are placed into 6 different groups depending on their placement and results in Period 1. Period 3 is the long-term extension period where participants will continue treatment from Period 2. Approximately 1328 adult and adolescent participants diagnosed with HS will be enrolled in approximately 300 sites worldwide.
Participants will receive oral tablets of upadacitinib or placebo once daily for 36 weeks in Period 1 and Period 2. Eligible participants from Period 1 and Period 2 will enter Period 3 and receive oral tablets of upadacitinib or placebo once daily for 68 weeks. Participants will be followed up for approximately 30 days.
There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular outpatient visits during the study. The effect of the treatment will be checked by medical assessments, checking for side effects and completing questionnaires.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Fase
- Fase 3
Contacten en locaties
Studie Locaties
-
-
-
Buenos Aires, Argentinië, 1061
- Centro de Investigacion y Prevencion Cardiovascular (CIPREC) /ID# 255474
-
CABA, Argentinië, C1199ABB
- Hospital Italiano /ID# 254905
-
-
Buenos Aires
-
Pilar, Buenos Aires, Argentinië, 1629
- Hospital Universitario Austral /ID# 254904
-
-
Buenos Aires F.D.
-
Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentinië, 1055
- Buenos Aires Skin /ID# 255299
-
Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentinië, 1425
- Instituto de Neumonologia y Dermatologia /ID# 254903
-
Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentinië, 1425
- Psoriahue Med Interdisciplinar /ID# 257202
-
Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentinië, 1428
- Consultorios Reumatologicos Pampa /ID# 255555
-
-
-
-
Australian Capital Territory
-
Phillip, Australian Capital Territory, Australië, 2606
- Paratus Clinical Research Woden /ID# 254670
-
-
New South Wales
-
Darlinghurst, New South Wales, Australië, 2010
- Momentum Clinical Research /ID# 254411
-
-
Victoria
-
Carlton, Victoria, Australië, 3053
- Skin Health Institute Inc /ID# 254416
-
East Melbourne, Victoria, Australië, 3002
- Sinclair Dermatology - Melbourne /ID# 254412
-
Melbourne, Victoria, Australië, 3004
- The Alfred Hospital /ID# 254414
-
-
-
-
-
Liège, België, 4000
- CHU de Liege /ID# 254085
-
-
Brussels Capital
-
Anderlecht, Brussels Capital, België, 1070
- Universite Libre de Bruxelles - Hopital Erasme /ID# 254082
-
Brussels, Brussels Capital, België, 1200
- Cliniques Universitaires UCL Saint-Luc /ID# 254087
-
Jette, Brussels Capital, België, 1090
- Universitair Ziekenhuis Brussel /ID# 254223
-
-
Hainaut
-
Charleroi, Hainaut, België, 6280
- Grand Hopital de Charleroi - Les Viviers /ID# 254091
-
-
Oost-Vlaanderen
-
Ghent, Oost-Vlaanderen, België, 9000
- UZ Gent /ID# 254090
-
-
Vlaams-Brabant
-
Leuven, Vlaams-Brabant, België, 3000
- Universitair Ziekenhuis Leuven /ID# 254089
-
-
-
-
-
Rio de Janeiro, Brazilië, 20241-180
- Instituto Brasil de Pesquisa Clinica S.A - IBPClin /ID# 275810
-
São Paulo, Brazilië, 05403-000
- Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao /ID# 254370
-
-
Rio Grande do Sul
-
Porto Alegre, Rio Grande do Sul, Brazilië, 90035-001
- Hospital Moinhos de Vento /ID# 254366
-
-
Rio de Janeiro
-
Macaé, Rio de Janeiro, Brazilië, 27910-190
- Instituto de Pesquisa e Ensino CLIGEDIMUNO - IPEC /ID# 254369
-
-
São Paulo
-
Campinas, São Paulo, Brazilië, 13034-685
- Hospital e Maternidade Celso Pierro - PUC-Campinas /ID# 275811
-
Ribeirão Preto, São Paulo, Brazilië, 14049-900
- Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto /ID# 254367
-
São Paulo, São Paulo, Brazilië, 04020-060
- Centro de Desenvolvimento em Estudos Clinicos Brasil - CDEC /ID# 254368
-
-
-
-
-
Sofia, Bulgarije, 1407
- Acibadem City Clinic Tokuda University Hospital EAD /ID# 253331
-
Stara Zagora, Bulgarije, 6000
- UMHAT Professor Stoyan Kirkovich /ID# 253328
-
-
Sofia
-
Sofiya, Sofia, Bulgarije, 1407
- Ambulatory for Specialized Medical Care-IPSMC-skin and venereal diseases /ID# 253329
-
Sofiya, Sofia, Bulgarije, 1463
- Diagnostic Consultative Centre (Dcc) - Foкus 5 /ID# 253327
-
-
-
-
-
Québec, Canada, G1V 4T3
- Diex Recherche Quebec Inc. /ID# 254381
-
-
Alberta
-
Calgary, Alberta, Canada, T2J 7E1
- Dermatology Research Institute - Blackfoot Trail /ID# 261413
-
Calgary, Alberta, Canada, T3A 2N1
- Beacon Dermatology /ID# 254564
-
Edmonton, Alberta, Canada, T5J 3S9
- Rejuvenation Dermatology - Edmonton Downtown /ID# 254715
-
Edmonton, Alberta, Canada, T6G 1C3
- Alberta Dermasurgery Centre /ID# 275945
-
Red Deer, Alberta, Canada, T4P 1K4
- Care Clinic - Red Deer - Taylor Drive /ID# 276063
-
-
British Columbia
-
Surrey, British Columbia, Canada, V3R 6A7
- Dr. Chih-ho Hong Medical Inc. /ID# 254378
-
Surrey, British Columbia, Canada, V3V 0C6
- Enverus Medical Research /ID# 254380
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R3M 3Z4
- Wiseman Dermatology Research /ID# 254117
-
-
Newfoundland and Labrador
-
St. John's, Newfoundland and Labrador, Canada, A1A 4Y3
- Karma Clinical Trials /ID# 254120
-
-
Ontario
-
Hamilton, Ontario, Canada, L8L 3C3
- LEADER Research /ID# 254379
-
London, Ontario, Canada, N6H 5L5
- DermEffects /ID# 254116
-
Markham, Ontario, Canada, L3P 1X2
- Lynderm Research /ID# 254713
-
Mississauga, Ontario, Canada, L4W 0C2
- Derm Care Clinic /ID# 276065
-
Newmarket, Ontario, Canada, L3Y 5G8
- Ryan Clinical Research Inc /ID# 254714
-
Richmond Hill, Ontario, Canada, L4C 9M7
- York Dermatology Clinic and Research Centre /ID# 254115
-
Toronto, Ontario, Canada, M4W 2N4
- Research Toronto /ID# 255273
-
-
Quebec
-
Montreal, Quebec, Canada, H3T 1C5
- Centre Hospitalier Universitaire (CHU) Sainte-Justine /ID# 254118
-
Saint-Jérôme, Quebec, Canada, J7Z 7E2
- Dre Angelique Gagne-Henley M.D. inc. /ID# 255632
-
-
Saskatchewan
-
Saskatoon, Saskatchewan, Canada, S7K 0H6
- SkinSense Dermatology /ID# 254119
-
-
-
-
Region Metropolitana Santiago
-
Las Condes, Region Metropolitana Santiago, Chili, 7580206
- Centro Medico Skin Med SPA /ID# 254560
-
Santiago, Region Metropolitana Santiago, Chili, 8420383
- Centro Internacional de Estudios Clinicos - CIEC /ID# 254559
-
Vitacura, Region Metropolitana Santiago, Chili, 7640881
- Clinica Dermacross /ID# 254558
-
-
Santiago Metropolitan
-
Independencia, Santiago Metropolitan, Chili, 8380465
- Fundacion Innovacion Cardiovascular /ID# 254561
-
-
-
-
Antioquia
-
Medellín, Antioquia, Colombia, 050012
- Clinica De Inmunologia Y Genetica (Cige) /ID# 254797
-
Medellín, Antioquia, Colombia, 050016
- IPS Suramericana SAS - IPS Sura San Diego /ID# 255064
-
-
Atlántico
-
Barranquilla, Atlántico, Colombia, 80002
- Centro Integral de Reumatologia del Caribe SAS - Circaribe SAS /ID# 255278
-
-
Cundinamarca
-
Bogotá, Cundinamarca, Colombia, 110221
- Centro de Investigacion en Reumatologia y especialidades Medicas S.A.S- CIREEM /ID# 254796
-
-
-
-
-
Berlin, Duitsland, 13595
- Havelklinik /ID# 254194
-
Magdeburg, Duitsland, 39104
- Magdeburger Company for Medical Studies & Services GmbH /ID# 255151
-
Mainz, Duitsland, 55128
- Dermatologie Quist-BAG Dres. med. Quist PartG /ID# 253691
-
-
Baden-Wurttemberg
-
Freiburg im Breisgau, Baden-Wurttemberg, Duitsland, 79106
- Universitaetsklinikum Freiburg /ID# 275746
-
-
Bavaria
-
Erlangen, Bavaria, Duitsland, 91054
- Universitaetsklinikum Erlangen /ID# 254804
-
Munich, Bavaria, Duitsland, 80802
- Klinikum rechts der Isar Technische Universitat Munchen /ID# 254195
-
Regensburg, Bavaria, Duitsland, 93042
- Universitaetsklinikum Regensburg /ID# 253692
-
Würzburg, Bavaria, Duitsland, 97080
- Universitaetsklinikum Wuerzburg /ID# 275599
-
-
Hesse
-
Frankfurt am Main, Hesse, Duitsland, 60590
- Universitaetsklinikum Frankfurt /ID# 253683
-
-
Lower Saxony
-
Bad Bentheim, Lower Saxony, Duitsland, 48455
- Fachklinik - Bad Bentheim /ID# 275537
-
Bramsche, Lower Saxony, Duitsland, 49565
- Studienzentrum an der Hase GbR Dr. Weyergraf/Dr. Frick/Thomas Heiber /ID# 254510
-
-
North Rhine-Westphalia
-
Bochum, North Rhine-Westphalia, Duitsland, 44791
- Universitaetsklinikum Der Ruhr-Universitaet Bochum /ID# 253690
-
Düsseldorf, North Rhine-Westphalia, Duitsland, 40225
- Universitaetsklinikum Duesseldorf /ID# 253711
-
-
Rhineland-Palatinate
-
Mainz, Rhineland-Palatinate, Duitsland, 55131
- Universitaetsmedizin Mainz /ID# 272596
-
-
Saarland
-
Merzig, Saarland, Duitsland, 66663
- Hautmedizin Saar Science /ID# 272614
-
-
-
-
North Ostrobothnia
-
Oulu, North Ostrobothnia, Finland, 90220
- Oulun yliopistollinen sairaala /ID# 253969
-
-
Pirkanmaa
-
Tampere, Pirkanmaa, Finland, 33100
- Terveystalo Tampere /ID# 253968
-
-
-
-
Alpes-Maritimes
-
Nice, Alpes-Maritimes, Frankrijk, 06202
- Chu De Nice-Hopital Larchet II /ID# 253504
-
-
Gironde
-
Bordeaux, Gironde, Frankrijk, 33000
- Centre Hospitalier Universitaire de Bordeaux - Groupe Hospitalier Saint-Andre /ID# 254139
-
-
Marne
-
Reims, Marne, Frankrijk, 51100
- Polyclinique Courlancy /ID# 254680
-
-
Pays de la Loire Region
-
Nantes, Pays de la Loire Region, Frankrijk, 44000
- Centre Hospitalier Universitaire de Nantes, Hotel Dieu -HME /ID# 254114
-
-
Rhone
-
Lyon, Rhone, Frankrijk, 69003
- HCL - Hopital Edouard Herriot /ID# 253500
-
-
Île-de-France Region
-
Antony, Île-de-France Region, Frankrijk, 92160
- Hopital Prive d'Antony /ID# 253501
-
-
-
-
-
Thessaloniki, Griekenland, 54643
- Hospital of Skin and Venereal Diseases- Thessaloniki /ID# 253497
-
Thessaloniki, Griekenland, 56429
- Papageorgiou General Hospital /ID# 253496
-
-
Attica
-
Athens, Attica, Griekenland, 11527
- 401 GSNA - 401 Army General Hospital /ID# 253499
-
Athens, Attica, Griekenland, 16121
- General Hospital Andreas Syggros /ID# 253498
-
Chaïdári, Attica, Griekenland, 12462
- University General Hospital Attikon /ID# 253495
-
-
-
-
-
Budapest, Hongarije, 1027
- Csalogany Orvosi Kozpont /ID# 255063
-
Budapest, Hongarije, 1036
- Duplicate_Obudai Egeszsegugyi Centrum Kft. /ID# 256366
-
Budapest, Hongarije, 1085
- Semmelweis Egyetem /ID# 276162
-
Debrecen, Hongarije, 4031
- DERMA-B Egeszsegugyi es Szolgaltato - Debrecen - Gyepusor Utca /ID# 253638
-
-
Baranya
-
Pécs, Baranya, Hongarije, 7624
- Pecsi Tudomanyegyetem Klinikai Kozpont /ID# 253753
-
-
Csongrád megye
-
Szeged, Csongrád megye, Hongarije, 6720
- Szegedi Tudomanyegyetem /ID# 255142
-
-
Hajdú-Bihar
-
Debrecen, Hajdú-Bihar, Hongarije, 4032
- Debreceni Egyetem-Klinikai Kozpont /ID# 253637
-
-
Somogy County
-
Kaposvár, Somogy County, Hongarije, 7400
- Somogy Varmegyei Kaposi Mor Oktato Korhaz /ID# 253913
-
-
Vas County
-
Szombathely, Vas County, Hongarije, 9700
- Vas Varmegyei Markusovszky Egyetemi Oktatokorhaz /ID# 254377
-
-
-
-
-
Cork, Ierland, T12 X23H
- South Infirmary Victoria University Hospital /ID# 253975
-
Dublin, Ierland, D04 T6F4
- St. Vincent's University Hospital /ID# 253971
-
Galway, Ierland, H91 YR71
- University Hospital Galway /ID# 253976
-
Waterford, Ierland, X91 ER8E
- Waterford Regional Hospital /ID# 254038
-
-
Dublin
-
Dublin, Dublin, Ierland, D08 NHY1
- St James Hospital /ID# 253973
-
-
-
-
-
Haifa, Israël, 3109601
- Rambam Health Care Campus /ID# 254406
-
-
Central District
-
Petah Tikva, Central District, Israël, 4941492
- Rabin Medical Center. /ID# 254405
-
-
Northern District
-
Safed, Northern District, Israël, 13100
- ZIV Medical Center /ID# 254403
-
-
Tel Aviv
-
Ramat Gan, Tel Aviv, Israël, 52621
- Sheba Medical Center /ID# 254545
-
Tel Aviv, Tel Aviv, Israël, 6423906
- Tel Aviv Sourasky Medical Center /ID# 254404
-
-
-
-
-
Brescia, Italië, 25123
- ASST degli Spedali Civili di Brescia /ID# 254875
-
Milan, Italië, 20122
- Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico /ID# 254502
-
Modena, Italië, 41124
- Azienda Ospedaliero-Universitaria di Modena /ID# 254874
-
Pisa, Italië, 56126
- Azienda Ospedaliero Universitaria Pisana /ID# 254501
-
-
Ferrara
-
Cona, Ferrara, Italië, 44124
- Azienda Ospedaliero-Universitaria di Ferrara - Arcispedale S.Anna /ID# 254496
-
-
Firenze
-
Florence, Firenze, Italië, 50122
- AZIENDA USL TOSCANA CENTRO - Ospedale Piero Palagi /ID# 254495
-
-
L Aquila
-
L’Aquila, L Aquila, Italië, 67100
- ASL 1 Abruzzo - Ospedale regionale San Salvatore /ID# 276045
-
-
Roma
-
Rome, Roma, Italië, 00133
- Azienda Ospedaliera Universitaria Policlinico Tor Vergata /ID# 254498
-
Rome, Roma, Italië, 00168
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Universita Cattolica /ID# 254500
-
-
-
-
Fukuoka
-
Fukuoka, Fukuoka, Japan, 814-0180
- Fukuoka University Hospital /ID# 254729
-
-
Hyōgo
-
Nishinomiya-shi, Hyōgo, Japan, 663-8186
- Meiwa Hospital /ID# 254728
-
-
Ibaraki
-
Tsukuba, Ibaraki, Japan, 305-8576
- University of Tsukuba Hospital /ID# 254638
-
-
Kyoto
-
Kyoto, Kyoto, Japan, 602-8566
- University Hospital Kyoto Prefectural University of Medicine /ID# 254481
-
-
Miyagi
-
Sendai, Miyagi, Japan, 9808574
- Tohoku University Hospital /ID# 254598
-
-
Okinawa
-
Ginowan-shi, Okinawa, Japan, 901-2725
- University of the Ryukyus Hospital /ID# 254517
-
-
Osaka
-
Sakai-shi, Osaka, Japan, 590-0197
- Kindai University Hospital /ID# 254574
-
-
Shiga
-
Ōtsu, Shiga, Japan, 520-2192
- Shiga University of Medical Science Hospital /ID# 254215
-
-
Tokyo
-
Minato-ku, Tokyo, Japan, 105-8470
- Toranomon Hospital /ID# 253819
-
tabashi City, Tokyo, Japan, 173-8610
- Nihon University Itabashi Hospital /ID# 254637
-
-
-
-
City of Zagreb
-
Zagreb, City of Zagreb, Kroatië, 10000
- DermaPlus - Poliklinika za dermatologiju i venerologiju /ID# 253587
-
Zagreb, City of Zagreb, Kroatië, 10000
- Klinicki bolnicki centar Zagreb /ID# 253786
-
Zagreb, City of Zagreb, Kroatië, 10000
- Klinika za dječje bolesti Zagreb /ID# 253588
-
Zagreb, City of Zagreb, Kroatië, 10000
- Poliklinika Solmed /ID# 254732
-
-
Primorje-Gorski Kotar County
-
Rijeka, Primorje-Gorski Kotar County, Kroatië, 51000
- Specialty Hospital Medico /ID# 254731
-
-
Split-Dalmatia County
-
Split, Split-Dalmatia County, Kroatië, 21000
- Klinicki Bolnicki Centar Split /ID# 253789
-
-
Zagreb County
-
Ivanić-Grad, Zagreb County, Kroatië, 10310
- Naftalan - Specijalna bolnica za medicinsku rehabilitaciju /ID# 253586
-
-
-
-
-
Vilnius, Litouwen, 08406
- Inlita - Santara KTC /ID# 253917
-
Vilnius, Litouwen, 08661
- Vilnius University Hospital Santaros Klinikos /ID# 253916
-
-
-
-
-
Mexico City, Mexico, 06100
- Cryptex Investigacion Clinica S.A de C.V /ID# 256066
-
-
Jalisco
-
Guadalajara, Jalisco, Mexico, 44657
- Grupo Clinico Catei Sociedad Civil /Id# 254657
-
-
Nuevo León
-
Monterrey, Nuevo León, Mexico, 64718
- Eukarya PharmaSite, SC /ID# 254658
-
-
-
-
-
Groningen, Nederland, 9713 GZ
- Universitair Medisch Centrum Groningen /ID# 253571
-
-
North Brabant
-
Breda, North Brabant, Nederland, 4818 CK
- Amphia Ziekenhuis /ID# 253567
-
-
-
-
Auckland
-
Epsom, Auckland, Nieuw-Zeeland, 1051
- Greenlane Clinical Centre /ID# 254351
-
-
Waikato Region
-
Hamilton, Waikato Region, Nieuw-Zeeland, 3204
- Clinical Trials New Zealand /ID# 254352
-
-
-
-
State of Vienna
-
Vienna, State of Vienna, Oostenrijk, 1090
- Medizinische Universitaet Wien /ID# 254096
-
-
Styria
-
Graz, Styria, Oostenrijk, 8010
- Medizinische Universitaet Graz /ID# 253448
-
-
Upper Austria
-
Linz, Upper Austria, Oostenrijk, 4010
- Duplicate_Ordensklinikum Linz GmbH Elisabethinen /ID# 253458
-
-
-
-
-
Lisbon, Portugal, 1998-018
- Hospital CUF Descobertas /ID# 254323
-
Porto, Portugal, 4099-001
- Centro Hospitalar Universitario do Porto, EPE - Hospital Santo Antonio /ID# 254322
-
Porto, Portugal, 4200-319
- Unidade Local de Saude Sao Joao /ID# 254324
-
-
Lisbon District
-
Lisbon, Lisbon District, Portugal, 1169-050
- Centro Hospitalar de Lisboa Central - Lisbon /ID# 254325
-
-
-
-
-
Caguas, Puerto Rico, 00727
- Dr. Samuel Sanchez PSC /ID# 253948
-
Carolina, Puerto Rico, 00985
- Alma M. Cruz Santana, MD-Private practice /ID# 253951
-
-
-
-
-
Riyadh, Saoedi-Arabië, 12372
- King Saud University Med City /ID# 255282
-
-
Mecca Region
-
Jeddah, Mecca Region, Saoedi-Arabië, 23433
- King Faisal Specialist Hospital /ID# 255539
-
-
Riyadh Region
-
Riyadh, Riyadh Region, Saoedi-Arabië, 11211
- King Faisal Specialist Hospital and Research Centre /ID# 255279
-
Riyadh, Riyadh Region, Saoedi-Arabië, 11426
- King Abdulaziz Medical City- National Guard Hospital /ID# 255280
-
-
-
-
-
Singapore, Singapore, 119074
- National University Hospital /ID# 254943
-
-
Central Singapore
-
Singapore, Central Singapore, Singapore, 308205
- National Skin Centre /ID# 255242
-
-
-
-
Bratislava Region
-
Bratislava, Bratislava Region, Slowakije, 821 01
- Univerzitna nemocnica Bratislava - Nemocnica Ruzinov /ID# 254157
-
-
Košice Region
-
Košice, Košice Region, Slowakije, 041 90
- Univerzitna nemocnica L. Pasteura Kosice /ID# 254136
-
-
Nitra Region
-
Nové Zámky, Nitra Region, Slowakije, 940 34
- Fakultna nemocnica s poliklinikou Nove Zamky /ID# 254155
-
-
Trnava Region
-
Trnava, Trnava Region, Slowakije, 917 02
- Fakultna nemocnica Trnava /ID# 254137
-
-
Žilina Region
-
Martin, Žilina Region, Slowakije, 036 01
- Univerzitna nemocnica Martin /ID# 254153
-
-
-
-
-
Barcelona, Spanje, 08041
- Hospital Santa Creu i Sant Pau /ID# 253869
-
Barcelona, Spanje, 08042
- Hospital General de Granollers /ID# 253873
-
Granada, Spanje, 18014
- Hospital Universitario Virgen de las Nieves /ID# 253870
-
Madrid, Spanje, 28034
- Hospital Universitario Ramon y Cajal /ID# 253871
-
Valencia, Spanje, 46026
- Hospital Universitario y Politecnico La Fe /ID# 253868
-
-
Barcelona
-
L'Hospitalet de Llobregat, Barcelona, Spanje, 08907
- Hospital Universitari de Bellvitge /ID# 254982
-
-
Madrid
-
Majadahonda, Madrid, Spanje, 28222
- Hospital Universitario Puerta de Hierro - Majadahonda /ID# 253924
-
-
Valencia
-
Manises, Valencia, Spanje, 46940
- Hospital de Manises /ID# 253867
-
-
-
-
-
Changhua City, Changhua County, Taiwan, 50006
- Changhua Christian Hospital /ID# 254032
-
Kaohsiung City, Taiwan, 833
- Kaohsiung Chang Gung Memorial Hospital /ID# 254031
-
Taipei, Taiwan, 100
- National Taiwan University Hospital /ID# 254030
-
Taoyuan City, Taiwan, 333
- Linkou Chang Gung Memorial Hospital /ID# 254033
-
-
-
-
-
Karlovy Vary, Tsjechië, 360 01
- Karlovarska Krajska Nemocnice - Karlovy Vary /ID# 253456
-
Prague, Tsjechië, 100 34
- Fakultni nemocnice Kralovske Vinohrady /ID# 253454
-
-
Praha 5
-
Prague, Praha 5, Tsjechië, 150 06
- Fakultni nemocnice Motol a Homolka /ID# 253455
-
-
-
-
-
Bayraklı, Turkije (Türkiye), 35540
- Izmir Sehir Hastanesi /ID# 265465
-
Bursa, Turkije (Türkiye), 16059
- Uludag University Medical Faculty /ID# 253806
-
Istanbul, Turkije (Türkiye), 34098
- Istanbul Universitesi-Cerrahpasa Cerrahpasa Tip Fakultesi /ID# 253824
-
Kayseri, Turkije (Türkiye), 38039
- Erciyes University Medical Faculty /ID# 253804
-
Samsun, Turkije (Türkiye), 55139
- Ondokuz Mayis Universitesi /ID# 254034
-
-
Antalya
-
Ankara, Antalya, Turkije (Türkiye), 06010
- Gulhane Egitim ve Arastirma Hastanesi /ID# 253919
-
-
-
-
-
Bristol, Verenigd Koninkrijk, BS1 3NU
- University Hospitals Bristol /ID# 261505
-
Salford, Verenigd Koninkrijk, M6 8HD
- Northern Care Alliance NHS Group /ID# 256910
-
-
Greater London
-
Isleworth, Greater London, Verenigd Koninkrijk, TW7 6AF
- West Middlesex University Hospital /ID# 254190
-
London, Greater London, Verenigd Koninkrijk, SW17 0QT
- St George University Hospitals NHS Foundation Trust /ID# 256803
-
-
Hampshire
-
Southampton, Hampshire, Verenigd Koninkrijk, SO16 6YD
- University Hospital Southampton NHS Foundation Trust /ID# 254531
-
-
Warwickshire
-
Coventry, Warwickshire, Verenigd Koninkrijk, CV2 2DX
- UH Coventry & Warwickshire /ID# 256909
-
-
West Yorkshire
-
Leeds, West Yorkshire, Verenigd Koninkrijk, LS9 7TF
- Leeds Teaching Hospitals NHS Trust /ID# 254616
-
-
-
-
Alabama
-
Birmingham, Alabama, Verenigde Staten, 35244
- Cahaba Dermatology and Skin Health Center /ID# 254876
-
-
Arizona
-
Fountain Hills, Arizona, Verenigde Staten, 85268
- Peak Dermatology Aesthetics and Wellness Fountain Hills /ID# 272564
-
Phoenix, Arizona, Verenigde Staten, 85006
- Medical Dermatology Specialists /ID# 254226
-
Scottsdale, Arizona, Verenigde Staten, 85259
- Mayo Clinic Hospital Scottsdale /ID# 254388
-
Tucson, Arizona, Verenigde Staten, 85718-1407
- Banner University Medicine Dermatology /ID# 255853
-
-
Arkansas
-
Fayetteville, Arkansas, Verenigde Staten, 72703
- Clinical Trials Institute - Northwest Arkansas /ID# 254924
-
Hot Springs, Arkansas, Verenigde Staten, 71913-6404
- Burke Pharmaceutical Research /ID# 254238
-
North Little Rock, Arkansas, Verenigde Staten, 72217
- Arkansas Research Trials /ID# 254233
-
Rogers, Arkansas, Verenigde Staten, 72758
- Northwest Arkansas Clinical Trials Center /ID# 254311
-
-
California
-
Encino, California, Verenigde Staten, 91436
- Private Practice - Dr. Tooraj Raoof /ID# 254374
-
Huntington Beach, California, Verenigde Staten, 92647
- Marvel Clinical Research /ID# 276228
-
Los Angeles, California, Verenigde Staten, 90045
- Dermatology Research Associates /ID# 254846
-
Rocklin, California, Verenigde Staten, 95765
- Norcal Clinical Research /ID# 274219
-
Sacramento, California, Verenigde Staten, 95815
- Integrative Skin Science and Research /ID# 254930
-
Sacramento, California, Verenigde Staten, 95817
- University of California Davis Health /ID# 254229
-
San Diego, California, Verenigde Staten, 92103
- Medderm Associates /ID# 253800
-
Thousand Oaks, California, Verenigde Staten, 91320-2130
- Clinical Trials Research Institute /ID# 254466
-
-
Connecticut
-
Farmington, Connecticut, Verenigde Staten, 06032
- UConn Health Main /ID# 254507
-
New Haven, Connecticut, Verenigde Staten, 06510
- Yale University School of Medicine /ID# 254586
-
-
Florida
-
Boca Raton, Florida, Verenigde Staten, 33486-2269
- Skin Care Research Boca Raton /ID# 253814
-
Brandon, Florida, Verenigde Staten, 33511
- Apex Clinical Trials /ID# 255756
-
Coral Gables, Florida, Verenigde Staten, 33134-5755
- Florida Academic Dermatology Center /ID# 254011
-
Coral Springs, Florida, Verenigde Staten, 33071
- Life Clinical Trials - Coral Springs /ID# 258613
-
Delray Beach, Florida, Verenigde Staten, 33445
- Dermatology Associates of the Palm Beaches /ID# 275950
-
Hollywood, Florida, Verenigde Staten, 33021-6748
- Skin Care Research - Hollywood /ID# 254508
-
Tampa, Florida, Verenigde Staten, 33607-6438
- Skin Care Research - Tampa /ID# 256440
-
Tampa, Florida, Verenigde Staten, 33607
- Advanced Clinical Research Institute - Tampa /ID# 253746
-
Tampa, Florida, Verenigde Staten, 33613-1825
- Avita Clinical Research /ID# 254471
-
-
Georgia
-
Columbus, Georgia, Verenigde Staten, 31904-2954
- Centricity Research - Columbus /ID# 255470
-
-
Idaho
-
Boise, Idaho, Verenigde Staten, 83706
- Treasure Valley Medical Research /ID# 255208
-
-
Illinois
-
Chicago, Illinois, Verenigde Staten, 60602
- Illinois Dermatology Institute - Chicago Loop Office /ID# 254372
-
Chicago, Illinois, Verenigde Staten, 60611
- Northwestern Medicine - Northwestern Memorial Hospital /ID# 254503
-
Skokie, Illinois, Verenigde Staten, 60077
- NorthShore University HealthSystem - Skokie /ID# 254389
-
-
Indiana
-
Indianapolis, Indiana, Verenigde Staten, 46256
- Dawes Fretzin /ID# 254390
-
West Lafayette, Indiana, Verenigde Staten, 47906
- Options Research Group /ID# 254537
-
-
Kansas
-
Leawood, Kansas, Verenigde Staten, 66211-1453
- U.S. Dermatology Partners Leawood /ID# 255838
-
-
Kentucky
-
Bowling Green, Kentucky, Verenigde Staten, 42104
- Equity Medical /ID# 271140
-
-
Massachusetts
-
Boston, Massachusetts, Verenigde Staten, 02114
- Massachusetts General Hospital /ID# 261093
-
Boston, Massachusetts, Verenigde Staten, 02215-5400
- Beth Israel Deaconess Medical Center /ID# 253811
-
Quincy, Massachusetts, Verenigde Staten, 02169
- Beacon Clinical Research, LLC /ID# 254419
-
Worcester, Massachusetts, Verenigde Staten, 01655
- UMass Memorial Medical Center - Lake Avenue North /ID# 258839
-
-
Michigan
-
Caledonia, Michigan, Verenigde Staten, 49316
- The Derm Institute Of West Michigan /ID# 275948
-
Canton, Michigan, Verenigde Staten, 48187
- Hamzavi Dermatology - Canton /ID# 275856
-
Clarkston, Michigan, Verenigde Staten, 48346
- Michigan Center for Medical Research - Clarkston /ID# 275860
-
Waterford, Michigan, Verenigde Staten, 48328
- Michigan Dermatology Institute /ID# 254468
-
-
Missouri
-
Kirksville, Missouri, Verenigde Staten, 63501-5362
- Cleaver Dermatology /ID# 254391
-
Lee's Summit, Missouri, Verenigde Staten, 64064-2301
- Dermatology and Skin Center of Lees Summit /ID# 257546
-
Saint Joseph, Missouri, Verenigde Staten, 64506
- MediSearch Clinical Trials /ID# 254392
-
St Louis, Missouri, Verenigde Staten, 63104
- SSM Health Saint Louis University Hospital /ID# 256437
-
St Louis, Missouri, Verenigde Staten, 63130
- Washington University School of Medicine - St. Louis /ID# 254506
-
-
Nevada
-
Las Vegas, Nevada, Verenigde Staten, 89119-5190
- Vivida Dermatology- Flamingo /ID# 254227
-
Las Vegas, Nevada, Verenigde Staten, 89144
- Las Vegas Dermatology /ID# 272421
-
Reno, Nevada, Verenigde Staten, 89509
- Skin Cancer and Dermatology Institute - Reno /ID# 254410
-
-
New York
-
East Syracuse, New York, Verenigde Staten, 13057
- Empire Dermatology /ID# 276241
-
New Hyde Park, New York, Verenigde Staten, 11042-2058
- NorthWell Health - Dermatology /ID# 254704
-
New York, New York, Verenigde Staten, 07044-2946
- Schweiger Dermatology, P.C. /ID# 254232
-
New York, New York, Verenigde Staten, 10012
- Private Practice - Dr. Bobby Buka /ID# 276371
-
-
North Carolina
-
Charlotte, North Carolina, Verenigde Staten, 28277
- OnSite Clinical Solutions - North Community House Road - Charlotte /ID# 254854
-
Durham, North Carolina, Verenigde Staten, 27710
- Duke University Medical Center /ID# 256898
-
-
Ohio
-
Canton, Ohio, Verenigde Staten, 44718
- Apex Clinical Research Center, LLC /ID# 275956
-
Columbus, Ohio, Verenigde Staten, 43213-4440
- ClinOhio Research Services /ID# 254851
-
Mason, Ohio, Verenigde Staten, 45040-4520
- Dermatologists of Southwest Ohio /ID# 254297
-
Medina, Ohio, Verenigde Staten, 44256
- Dermatology Partners - Medina /ID# 275939
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Verenigde Staten, 73112
- Lynn Institute of Oklahoma City /ID# 253791
-
-
Oregon
-
Portland, Oregon, Verenigde Staten, 97239
- Oregon Health and Science University /ID# 254929
-
-
Pennsylvania
-
Hershey, Pennsylvania, Verenigde Staten, 17033-2360
- Penn State Milton S. Hershey Medical Center /ID# 254925
-
Philadelphia, Pennsylvania, Verenigde Staten, 19103
- Paddington Testing Co., Inc. /ID# 254394
-
Philadelphia, Pennsylvania, Verenigde Staten, 19114
- Clinical Research of Philadelphia, LLC /ID# 255308
-
-
South Carolina
-
Charleston, South Carolina, Verenigde Staten, 29425
- Medical University of South Carolina /ID# 272569
-
-
Tennessee
-
Knoxville, Tennessee, Verenigde Staten, 37917
- Dermatology Associates of Knoxville /ID# 261082
-
-
Texas
-
Arlington, Texas, Verenigde Staten, 76011
- Arlington Research Center, Inc /ID# 253805
-
Bellaire, Texas, Verenigde Staten, 77401
- Bellaire Dermatology Associates /ID# 253797
-
Dallas, Texas, Verenigde Staten, 75230
- Dermatology Treatment and Research Center /ID# 253795
-
Dallas, Texas, Verenigde Staten, 75231
- Modern Research Associates /ID# 253810
-
Dallas, Texas, Verenigde Staten, 75240-6246
- HRMD Research Dallas /ID# 255256
-
Grapevine, Texas, Verenigde Staten, 76051-3580
- Dallas Fort Worth Clinical Research Associates (DFWCRA) /ID# 256438
-
Houston, Texas, Verenigde Staten, 77056
- Suzanne Bruce and Associates-Houston /ID# 254228
-
Plano, Texas, Verenigde Staten, 75025
- Texas Dermatology Research Center /ID# 254928
-
Webster, Texas, Verenigde Staten, 77598
- Center for Clinical Studies Webster /ID# 254242
-
-
Utah
-
Bountiful, Utah, Verenigde Staten, 84010
- Cope Family Medicine - Ogden Clinic /ID# 276227
-
Murray, Utah, Verenigde Staten, 84107
- University of Utah - Murray /ID# 254452
-
Springville, Utah, Verenigde Staten, 84663
- Springville Dermatology - Springville /ID# 276225
-
-
Virginia
-
Charlottesville, Virginia, Verenigde Staten, 22903
- University of Virginia - Dermatology /ID# 254535
-
Lynchburg, Virginia, Verenigde Staten, 24501-1403
- The Education & Research Foundation, Inc. /ID# 254852
-
Norfolk, Virginia, Verenigde Staten, 23507
- Virginia Clinical Research /ID# 254538
-
-
Washington
-
Mill Creek, Washington, Verenigde Staten, 98012
- Frontier Dermatology /ID# 254554
-
Spokane, Washington, Verenigde Staten, 99202
- Premier Clinical Research /ID# 254847
-
-
-
-
Gyeonggido
-
Ansan-si, Gyeonggido, Zuid -Korea, 15355
- Korea University Ansan Hospital /ID# 254128
-
Seongnam, Gyeonggido, Zuid -Korea, 13496
- CHA Bundang Medical Center /ID# 254026
-
-
Seoul Teugbyeolsi
-
Seoul, Seoul Teugbyeolsi, Zuid -Korea, 03080
- Seoul National University Hospital /ID# 254027
-
Seoul, Seoul Teugbyeolsi, Zuid -Korea, 04401
- SoonChunHyang University Seoul Hospital /ID# 254025
-
Seoul, Seoul Teugbyeolsi, Zuid -Korea, 07441
- Hallym University Kangnam Sacred Heart Hospital /ID# 254127
-
-
-
-
Stockholm County
-
Solna, Stockholm County, Zweden, 171 64
- Karolinska University Hospital Solna /ID# 254808
-
-
Västra Götaland County
-
Gothenburg, Västra Götaland County, Zweden, 413 46
- Sahlgrenska Universitetssjukhuset /ID# 254807
-
-
-
-
-
Bern, Zwitserland, 3010
- Inselspital, Universitaetsspital Bern /ID# 254736
-
-
Canton of St. Gallen
-
Sankt Gallen, Canton of St. Gallen, Zwitserland, 9007
- Kantonsspital St. Gallen /ID# 255243
-
-
Canton of Zurich
-
Zurich, Canton of Zurich, Zwitserland, 8091
- University Hospital Zurich /ID# 254642
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Diagnosis of hidradenitis suppurativa (HS) for at least 6 months prior to Baseline, as determined by the investigator (i.e., through medical history and interview of participant).
- Documented history of previous use of >= 1 tumor necrosis factor (TNF) inhibitor for HS for at least 12 weeks and/or 1 approved non-anti-TNF biologic therapy for HS for at least 16 weeks characterized by inadequate response or for any duration characterized by intolerance as determined by the investigator.
- Participant must have a total abscess and inflammatory nodule (AN) count of >= 5 at Baseline.
- HS lesions must be present in at least 2 distinct anatomic areas at Baseline.
- At least 1 anatomic area of HS involvement characterized as Hurley Stage II or higher at Baseline.
- Draining fistula count of <= 20 at Baseline.
Exclusion Criteria:
- History of active skin disease other than HS that could interfere with the assessment of HS, including skin infections (bacterial, fungal, or viral) requiring systemic treatment within 4 weeks of the Baseline visit.
- Treatment with any investigational drug of chemical or biologic nature within a minimum of 30 days or 5 half-lives (whichever is longer) prior to the first dose of study drug or be currently enrolled in another interventional clinical study. Investigational drugs are also prohibited during the study.
- Previous treatment with any cell-depleting therapies including but not limited to anti-CD20 (e.g., rituximab) within 12 months prior to Baseline or until B cell count returns to normal level or pre-treatment level.
- Use of prescription topical therapies (including topical antibiotics) that can also be used to treat HS within 14 days prior to the Baseline visit.
- Received any systemic (including oral) antibiotic treatment for HS or any other chronic inflammatory disorder within 14 days prior to the Baseline visit.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Verviervoudigen
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Period 1: Upadacitinib Dose A
Participants will receive Upadicitinib Dose A once daily for 16 weeks. |
Oral Tablets
Andere namen:
|
|
Placebo-vergelijker: Period 1: Placebo
Participants will receive Placebo once daily for 16 weeks. |
Oral Tablets |
|
Experimenteel: Period 2: Group 1 - Upadacitinib Dose A
Participants who were randomized to placebo in Period 1 who did not achieve HiSCR 50 (clinical non-responder, CNR) at Week 16 will receive Upadacitinib Dose A once daily for 20 weeks. |
Oral Tablets
Andere namen:
|
|
Placebo-vergelijker: Period 2: Group 2 - Placebo
Participants who were randomized to placebo in Period 1 who achieve HiSCR 50 (clinical responder, CR) at Week 16 will continue to receive placebo once daily for 20 weeks. |
Oral Tablets |
|
Experimenteel: Period 2: Group 3 - Upadacitinib Dose A
Participants who were randomized to upadacitinib Dose A in Period 1 who did not achieve HiSCR 50 (CNR) at Week 16 will continue to receive upadacitinib Dose A once daily for 20 weeks. |
Oral Tablets
Andere namen:
|
|
Experimenteel: Period 2: Group 4 - Upadacitinib Dose A
Participants who were randomized to upadacitinib Dose A in Period 1 who achieve HiSCR 50 (CR) at Week 16 will receive upadacitinib Dose A once daily for 20 weeks. |
Oral Tablets
Andere namen:
|
|
Experimenteel: Period 2: Group 5 - Upadacitinib Dose B
Participants who were randomized to upadacitinib Dose A in Period 1 who achieve HiSCR 50 (CR) at Week 16 will receive upadacitinib Dose B once daily for 20 weeks. |
Oral Tablets
Andere namen:
|
|
Experimenteel: Period 2: Group 6 - Placebo
Participants who were randomized to upadacitinib Dose A in Period 1 who achieve HiSCR 50 (CR) at Week 16 will receive placebo once daily for 20 weeks. |
Oral Tablets |
|
Experimenteel: Period 3: Long-Term Extension
Eligible participants will continue to receive upadacitinib or placebo for 68 weeks. Participants will be followed-up for approximately 30 days. |
Oral Tablets
Andere namen:
Oral Tablets |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Percentage of Participants Achieving Hidradenitis Suppurative Clinical Response (HiSCR) 50
Tijdsspanne: Baseline to Week 16
|
HiSCR 50 is defined as at least a 50% reduction in the total abscess and inflammatory nodule (AN) count with no increase in abscess count and no increase in draining fistula count relative to Baseline. |
Baseline to Week 16
|
|
Number of Participants with Adverse Events (AEs)
Tijdsspanne: Up to Approximately Week 108
|
An AE is defined as any untoward medical occurrence in a patient or clinical investigation in which a participant is administered a pharmaceutical product which does not necessarily have a causal relationship with this treatment. |
Up to Approximately Week 108
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change from Baseline in Draining Fistula Count
Tijdsspanne: Baseline to Week 16
|
Change from baseline in draining fistula count. |
Baseline to Week 16
|
|
Percentage of Participants Achieving Hidradenitis Suppurative Clinical Response (HiSCR) 75
Tijdsspanne: Baseline to Week 16
|
HiSCR 75 is defined as at least a 75% reduction in the total abscess and inflammatory nodule (AN) count with no increase in abscess count and no increase in draining fistula count relative to Baseline. |
Baseline to Week 16
|
|
Percentage of Participants Achieving Numeric Rating Scale 30 (NRS30) at Week 4 Among Participants with NRS ≥ 3 at Baseline
Tijdsspanne: Baseline to Week 4
|
Achievement will be considered at least a 30% reduction and at least 2 units reduction from Baseline in the Participant's Global Assessment (PGA) of HS-related skin pain NRS based on worst skin pain in a 24-hour recall period (maximal daily pain). The PGA Skin Pain is an 11-point numerical rating scale with ratings for the item ranging from 0 (no skin pain) to 10 (skin pain as bad as you can imagine). |
Baseline to Week 4
|
|
Percentage of Participants Achieving NRS3 at Week 4 Among Participants with NRS ≥ 3 at Baseline
Tijdsspanne: Baseline to Week 4
|
Achievement will be considered least 3 units reduction from Baseline in the Participant's Global Assessment (PGA) of HS-related skin pain NRS based on worst skin pain in a 24-hour recall period (maximal daily pain). The PGA Skin Pain is an 11-point numerical rating scale with ratings for the item ranging from 0 (no skin pain) to 10 (skin pain as bad as you can imagine). |
Baseline to Week 4
|
|
Change from Baseline in Hidradenitis Suppurativa Symptom Assessment (HSSA)
Tijdsspanne: Baseline to Week 16
|
The HSSA (24-hour recall) is a 9-item PRO questionnaire developed to assess the primary symptoms of HS in the 7 consecutive days prior to assessments. Each item of the HSSA is scored on an 11-point (0 to 10) NRS, where 0 represents no symptoms and 10 represents extreme symptom experience. |
Baseline to Week 16
|
|
Change from Baseline in Hidradenitis Suppurativa Impact Assessment (HSIA)
Tijdsspanne: Baseline to Week 16
|
The HSIA is an 18-item PRO questionnaire developed to assess the impact of HS on the daily lives of subjects in the 7 days prior to the assessment. Items 1 - 16 of the HSIA are scored on a 0 to 10 NRS, where 0 represents no impact and 10 represents extreme impact. |
Baseline to Week 16
|
|
Change from Baseline in Dermatology Life Quality Index (DLQI) for Adult Participants and Adolescent Participants Age ≥16 Years Old and Older
Tijdsspanne: Baseline to Week 16
|
The DLQI and the CDLQI are both 10-item questionnaires used to assess the impact of hidradenitis suppurativa (HS) disease symptoms and treatment on quality of life that consists of 10 questions scored on a 4-point scale where 0 = not at all/not relevant; 1 = a little; 2 = a lot; and 3 = very much. |
Baseline to Week 16
|
|
Occurrence of Hidradenitis Suppurativa (HS) Flare During Period 1
Tijdsspanne: Baseline to Week 16
|
Defined as at least one occurrence of a ≥ 25% increase in AN count, with a minimum absolute increase of 2 relative to Baseline. |
Baseline to Week 16
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Studie directeur: ABBVIE INC., AbbVie
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- M23-698
- 2023-503661-28-00 (Andere identificatie: EU CT)
- 2023 (Subsidie/contract van de Amerikaanse NIH)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
AbbVie is committed to responsible clinical trial data sharing. This includes access to anonymized, individual and trial-level data (analysis data sets), as well as other information.
IPD-tijdsbestek voor delen
For details on when studies are available for sharing visit https://vivli.org/ourmember/abbvie/
IPD-toegangscriteria voor delen
To learn more about the process, or to submit a request, visit the following link https://www.abbvieclinicaltrials.com/hcp/data-sharing/
IPD delen Ondersteunend informatietype
- LEERPROTOCOOL
- SAP
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
product vervaardigd in en geëxporteerd uit de V.S.
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .